Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Immune Thrombocytopenia Pathogenesis: a Multicenter, Open and Controlled Study.

NCT02042560 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT02042560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Immune Thrombocytopenia Pathogenesis: a Multicenter, Open and Controlled Study.
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Completed
Start date
May 4, 2011
Completion date
March 12, 2015
Enrollment
89 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune thrombocytopenia (itp)